Medical Marijuana for Parkinson's Disease in Washington State

Parkinson's disease (PD) is a progressive neurological condition characterized by tremors, rigidity, bradykinesia (slowness of movement), and a range of non-motor symptoms including sleep disorders, anxiety, pain, and cognitive changes. Washington State explicitly recognizes Parkinson's disease as a qualifying condition for medical marijuana.

Does Parkinson's qualify for Washington medical marijuana?

Yes. Washington's medical cannabis statute (RCW 69.51A) lists Parkinson's disease by name. Any confirmed PD diagnosis from a neurologist or movement disorder specialist satisfies the requirement. Lewy body dementia and other Parkinsonian syndromes may also qualify under the broader "terminal or debilitating condition" language.

How cannabis may help with Parkinson's symptoms

Research on cannabis in Parkinson's is more limited than for some other conditions, but emerging evidence is encouraging:

• Tremor and rigidity — some clinical reports and observational studies suggest cannabis reduces tremor severity and muscle rigidity. A 2014 study in the Journal of Psychoactive Drugs found statistically significant improvement in tremor, rigidity, and bradykinesia scores after cannabis use in PD patients.
• Sleep disorders — REM sleep behavior disorder (RBD) is extremely common in PD and can be dangerous. CBD in particular has shown promise for RBD — acting on REM sleep without the sedation or dependence risk of prescription sleep aids
• Pain — PD-related pain (dystonia pain, musculoskeletal pain from rigidity) responds to cannabis similarly to other neuropathic and inflammatory pain conditions
• Anxiety and mood — non-motor symptoms like anxiety and depression are highly prevalent in PD and often undertreated. CBD shows anxiolytic and antidepressant-adjacent effects
• Dyskinesias — some evidence suggests CBD may reduce levodopa-induced dyskinesias (involuntary movements that develop with long-term PD medication use)

Considerations for Parkinson's patients

• Motor coordination and fall risk — THC at higher doses can impair balance and coordination. For PD patients with already compromised gait and balance, starting with very low doses and CBD-dominant products is important
• Cognitive effects — patients with cognitive changes should be particularly cautious with high-THC products, which can worsen confusion and memory
• Interaction with PD medications — cannabis generally has a favorable interaction profile with common PD drugs (levodopa/carbidopa, dopamine agonists), but check with your provider about your full medication list
• Route of administration — smoking may be difficult for patients with swallowing or respiratory issues. Tinctures under the tongue or transdermal patches avoid these limitations

Getting your authorization

Bring documentation of your Parkinson's diagnosis from your neurologist or movement disorder specialist. Your Green Wellness provider will discuss which cannabis approaches make sense given your symptom profile, current medications, and functional level.

Same-day appointments are available at all four Green Wellness locations — Lynnwood, Spokane, Olympia, and Vancouver. Telehealth is available for returning patients.

Book your Parkinson's evaluation — $175 →